News
RPM to Announce Fiscal 2022 Fourth-Quarter and Year-End Results on July 25, 2022
RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2022 fourth quarter and year ended May 31, 2022, before the stock market opens on
Hexcel Schedules Second Quarter 2022 Earnings Release and Conference Call
Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its second quarter of 2022 on Monday, July 25 after the market close.
The company will host a webcast and
Tennessee Gas Pipeline Receives FERC Approval for Producer Certified Gas Pooling Service Proposal
Tennessee Gas Pipeline Company, L.L.C. (TGP), a subsidiary of Kinder Morgan, Inc. (NYSE: KMI) today received approval for its producer certified gas (PCG), or responsibly sourced gas (RSG)
Novocure to Report Second Quarter 2022 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2022 on Thursday, July 28, 2022, before the U.S. financial markets open. Novocure’s management
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Prescott Dirt Joins SiteOne Landscape Supply
SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today the acquisition of Prescott Dirt, a distributor of landscape supplies with two locations in Prescott and Prescott Valley, Arizona.
“We
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Kohl’s Concludes Strategic Review Process
Kohl’s Corporation ("Kohl’s" or the "Company") (NYSE: KSS) announced today that following the exclusive negotiation period with Franchise Group (“FRG”), the Kohl’s Board of Directors (the “Board”)
Newron Extends Senior Management Team and Strengthens Commitment to ESG
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
DGAP-News: Bitcoin Group SE holds Annual General Meeting 2022 - dividend of EUR 0.10 per share resolved